Cancer News and Research

Latest Cancer News and Research

2012 & health care: Medicare faces big changes, new state laws include abortion issues

News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.

2 Jan 2012

Hospitals may be treating patients as part of “production line” with early discharges requiring readmissions: Report

After figures revealed that hundreds of thousands of people every year are being sent home before they are well enough, hospitals have been accused by ministers of treating patients “like parts on a production line.”

1 Jan 2012

Four or more coffees reduce risk of womb cancer

According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.

1 Jan 2012

Britain mulling on cigarette plain packaging to discourage smoking

Britain wishes to follow Australia’s footsteps in banning all eye-catching designs and branding from cigarette packs to stop young people being lured into smoking. Australia meanwhile is poised to become the first nation to introduce so-called “plain” packaging on tobacco products by the end of 2012. The packs will show graphic health warnings about smoking but banish attractive colors and logos. The proposed law was cleared by parliament in November and is being closely watched by governments considering similar moves in Europe, Canada and New Zealand.

1 Jan 2012

Similar sounding drug names should come with warnings

There have been mix ups and medication errors with similar sounding names of drugs - eye drops called Durezol and salicylic acid-containing wart remedy Duresal for example.

1 Jan 2012

ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program

ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.

31 Dec 2011

CHEST Foundation awards $100,000 for development of blood test for lung cancer

Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage.

31 Dec 2011

Lucid closes underwritten public offering

Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.

31 Dec 2011

China's revised Foreign Investment Catalogue 2011 moves healthcare service sectors to 'permitted' category

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, comments on the newly issued Foreign Investment Catalogue 2011 revision which moved healthcare service sectors to "permitted" from "restricted" category.

31 Dec 2011

Additional financing to fund Advaxis' cervical cancer trials

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has entered into a definitive Convertible Notes Purchase Agreement (Agreement) with certain accredited investors, for the purchase of the aggregate principal value of approximately $1.2 million of Convertible Promissory Notes (Notes) for an aggregate purchase price of approximately $1.0 million.

31 Dec 2011

St. Michael's Hospital endocrinologist receives Novo Nordisk Diabetes Innovation Award

Dr. Andrew Advani, an endocrinologist at St. Michael's Hospital, is one of 10 researchers in North America who received a newly created Novo Nordisk Diabetes Innovation Award.

30 Dec 2011

Van Andel studies distinguish cancer subtypes and provide promising new drug targets

Two recent studies by Van Andel Research Institute scientists are providing a foundation for a more complete understanding of distinct kidney cancer subtypes, which could pave the way for better treatments.

30 Dec 2011

FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prostate cancer

Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.

30 Dec 2011

Single shared REMS for TIRF products receives FDA approval

The U.S. Food and Drug Administration today approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for the transmucosal immediate-release fentanyl (TIRF) products. This new shared system will replace the individual REMS and allow prescribers and pharmacies to enroll into just one system, easing the burden on the health care system.

30 Dec 2011

Meditation, yoga and physical awareness benefit breast cancer survivors

Women recently diagnosed with breast cancer have higher survival rates than those diagnosed in previous decades, according to the American Cancer Society. However, survivors continue to face health challenges after their treatments end. Previous research reports as many as 50 percent of breast cancer survivors are depressed.

30 Dec 2011

Most paramedics experience verbal, physical or sexual abuse on the job

More than two-thirds of paramedics surveyed have experienced verbal, physical or sexual abuse on the job, new research has found.

30 Dec 2011

ATM gene mutations may increase hereditary risk for pancreatic cancer

Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.

30 Dec 2011

Avastin fails to live up to expectations for extending survival in ovarian cancer

Cancer drug Avastin has been found to add about four months to the time it takes for the cancer to worsen for women with advanced cases of ovarian cancer says a new report. However it may not extend survival significantly.

29 Dec 2011

Venezuela offers to pay for removal of faulty breast implants

Venezuela's government has offered to pay for the removal of PIP breast implants feared to be at risk of rupture. They would cover the cost of the surgery for Venezuelan women but would not pay for replacement implants, Health Minister Eugenia Sader said. Ms Sader said many implants made by French firm Poly Implant Prothese (PIP) had been imported illegally.

29 Dec 2011

Free, low-cost strategies to maintain good health in the new year

With the start of a new year, Dana-Farber Cancer Institute experts are encouraging people to ring in new healthy habits and offer a number of free and low-cost strategies to help people maintain good health and possibly reduce various cancer risks.

29 Dec 2011

Cancer News and Research

Latest Cancer News and Research

2012 & health care: Medicare faces big changes, new state laws include abortion issues

Hospitals may be treating patients as part of “production line” with early discharges requiring readmissions: Report

Four or more coffees reduce risk of womb cancer

Britain mulling on cigarette plain packaging to discourage smoking

Similar sounding drug names should come with warnings

ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program

CHEST Foundation awards $100,000 for development of blood test for lung cancer

Lucid closes underwritten public offering

China's revised Foreign Investment Catalogue 2011 moves healthcare service sectors to 'permitted' category

Additional financing to fund Advaxis' cervical cancer trials

St. Michael's Hospital endocrinologist receives Novo Nordisk Diabetes Innovation Award

Van Andel studies distinguish cancer subtypes and provide promising new drug targets

FDA invites Amgen for ODAC meeting on XGEVA sBLA to treat castration-resistant prostate cancer

Single shared REMS for TIRF products receives FDA approval

Meditation, yoga and physical awareness benefit breast cancer survivors

Most paramedics experience verbal, physical or sexual abuse on the job

ATM gene mutations may increase hereditary risk for pancreatic cancer

Avastin fails to live up to expectations for extending survival in ovarian cancer

Venezuela offers to pay for removal of faulty breast implants

Free, low-cost strategies to maintain good health in the new year

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in